Trial: 202112016

A Randomized, Blinded, Placebo-controlled, Phase 2 Study of INBRX-109 in Unresectable or Metastatic Conventional Chondrosarcoma

Phase

II

Principal Investigator

Van Tine, Brian

Disease Site

Bones and Joints

Learn more about this study at: clinicaltrials.gov